ACM
ADAP

ACT Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

ACT Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		$97K Hold
90,000
– – 0.13% 49
2022
Q2 		$153K Hold
90,000
– – 0.21% 43
2022
Q1 		$185K Hold
90,000
– – 0.2% 52
2021
Q4 		$338K Hold
90,000
– – 0.24% 54
2021
Q3 		$465K Buy
+90,000
New +$465K 0.24% 62